Biotech firm settles class action lawsuit over ransomware attack for $7.5 million

Summary: Enzo Biochem, a large biotech company, has settled a class action lawsuit for $7.5 million following a ransomware attack that compromised the personal data of approximately 2.5 million individuals. The attack revealed sensitive information, including names and Social Security numbers, and highlighted significant cybersecurity vulnerabilities within the company. This settlement comes in the wake of previous penalties and increased scrutiny on healthcare organizations regarding ransomware incidents.

Threat Actor: Unknown | unknown
Victim: Enzo Biochem | Enzo Biochem

Keypoints :

• Enzo Biochem faced a ransomware attack in April 2023, leading to unauthorized access to clinical test information of nearly 2.5 million individuals.
• The company has committed to enhancing its data protection systems following the attack, which involved compromised employee login credentials.
• The U.S. Department of Health and Human Services has reported a significant increase in ransomware attacks targeting healthcare organizations.